全文获取类型
收费全文 | 323篇 |
免费 | 10篇 |
出版年
2023年 | 1篇 |
2022年 | 2篇 |
2021年 | 1篇 |
2020年 | 2篇 |
2019年 | 2篇 |
2018年 | 3篇 |
2017年 | 5篇 |
2016年 | 11篇 |
2015年 | 16篇 |
2014年 | 19篇 |
2013年 | 12篇 |
2012年 | 26篇 |
2011年 | 24篇 |
2010年 | 21篇 |
2009年 | 14篇 |
2008年 | 23篇 |
2007年 | 34篇 |
2006年 | 28篇 |
2005年 | 24篇 |
2004年 | 17篇 |
2003年 | 16篇 |
2002年 | 20篇 |
2001年 | 3篇 |
1998年 | 2篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1994年 | 1篇 |
1992年 | 1篇 |
1989年 | 1篇 |
1981年 | 1篇 |
排序方式: 共有333条查询结果,搜索用时 0 毫秒
331.
Differences in Stem Cell Processing Lead to Distinct Secretomes Secretion—Implications for Differential Results of Previous Clinical Trials of Stem Cell Therapy for Myocardial Infarction 下载免费PDF全文
332.
333.
Jean-Claude Daubresse Jaroslaw Kolanowski Georges Krzentowski Maximilien Kutnowski Andre Scheen Luc Van Gaal 《Obesity (Silver Spring, Md.)》1996,4(4):391-396
Weight reduction is essential in the management of most noninsulin-dependent diabetics, but this therapeutical goal is difficult to obtain. In this double-blind parallel study, 82 noninsulin-dependent diabetics, moderately obese (BMI = 30–39 kg/nr2), were given for an 8-week period either placebo (P) or fluoxetine (F), a specific serotonin reuptake inhibitor, in addition to their usual antidiabetic treatment. Thirty-nine of them received 60 mg fluoxetine a day and 43 were given the placebo. At admission, both groups had similar weight excess, metabolic control and serum lipid values. In comparison with the P-treated subjects, those treated with fluoxetine (F) lost more weight after 3 weeks (-1.9 vs. ?0.7 kg, p<0.0009) and after 8 weeks (-3.1 vs. ?0.9 kg, p<0.0007). Fasting blood glucose decreased in group F after 3 weeks (- 1.5 vs. ?0.4 mmol/L, p<0.003) and after 8 weeks (-1.7 vs. ?0.02 mmol/L, p<0.0004). HbAlc decreased from 8.5% to 7.7% in group F and from 8.6% to 8.3% in group P (p=0.057). Mean triglyceride level was also reduced in group F after 8 weeks (p=0.042). Fasting C-pep-tide did not change in either group, but fasting insulin values decreased in group F after 3 weeks (p<0.02) and after 8 weeks (p<0.05). The insulin/C-peptide molar ratio decreased significantly in group F after 3 weeks (p<0.04) and after 8 weeks (p<0.05) in comparison with group P. The drug was generally well tolerated and no major side effects were reported. In conclusion, the addition of fluoxetine to the usual oral hypoglycemic agent therapy might be beneficial in obese non-insulin-dependent diabetics, at least on a short-term basis. 相似文献